# Study Evaluating Management of Patients With Moderate and Severe Psoriasis

> **NCT00894777** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 469 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **OTHER:** Clinical record review

## Key facts

- **NCT ID:** NCT00894777
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 469 (ACTUAL)
- **Last updated:** 2010-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894777, "Study Evaluating Management of Patients With Moderate and Severe Psoriasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00894777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*